Zepp Health Corporation
ZEPP
$2.36
-$0.175-6.90%
NYSE
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -28.27% | -48.91% | -57.57% | -57.57% | -44.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -28.27% | -48.91% | -57.57% | -57.57% | -44.96% |
| Cost of Revenue | -30.57% | -54.10% | -68.10% | -68.10% | -54.71% |
| Gross Profit | -23.95% | -38.78% | -2.08% | -2.08% | -7.64% |
| SG&A Expenses | 15.93% | 15.20% | -13.54% | -13.54% | -31.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.87% | -32.71% | -52.00% | -52.00% | -48.77% |
| Operating Income | -1,527.80% | -1,009.14% | 28.17% | 28.17% | 106.27% |
| Income Before Tax | -1,643.81% | -4,093.67% | 37.95% | 37.95% | 113.72% |
| Income Tax Expenses | 389.15% | -- | 101.98% | 101.98% | 887.46% |
| Earnings from Continuing Operations | -2,819.38% | -5,084.59% | 26.39% | 26.39% | 88.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 266.67% | -70.37% | 13.38% | 13.38% | -154.74% |
| Net Income | -2,783.19% | -4,622.53% | 26.45% | 26.45% | 87.97% |
| EBIT | -1,527.80% | -1,009.14% | 28.17% | 28.17% | 106.27% |
| EBITDA | -401.50% | -412.82% | 29.97% | 29.97% | 132.17% |
| EPS Basic | -2,608.26% | -4,351.30% | 30.52% | 30.52% | 87.81% |
| Normalized Basic EPS | -615.90% | -2,892.47% | 34.33% | 34.33% | 120.69% |
| EPS Diluted | -1,362.95% | -5,228.13% | 30.23% | 30.23% | 77.55% |
| Normalized Diluted EPS | -615.90% | -3,051.14% | 34.33% | 34.33% | 120.69% |
| Average Basic Shares Outstanding | 6.51% | 6.27% | 5.87% | 5.87% | -1.37% |
| Average Diluted Shares Outstanding | 6.51% | 0.88% | 5.87% | 5.87% | -1.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |